Myriad Genetics, Inc. Salt Lake City, UT 84108. (801) 584-1175 Myriad Customer Service Data Provided by Refinitiv. cscomments@myriad.com, Decrease costs while improving patient well-being, Accurate test results drive optimal treatments. (801) 584-3065 Myriad Genetics, Inc. (801) 584-1175 Salt Lake City, UT 84108. If you are a payer or insurance provider, please contact us to receive more information. Ron Rogers 320 Wakara Way (801) 584-1143 Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. Myriad RBM; Address. cumulative factor which encapsulates all splits since the date shown above. Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors. rrogers@myriad.com, Scott Gleason What You Need to Know About Hereditary Colon Cancer, Video – Pioneering Advances in Personalized Medicine, Notice and Statement Concerning Nondiscrimination and Accessibility. (801) 584-1175 adjusted to account for any stock splits and/or dividends which may have VP, Investor Relations 800-4-MYRIAD (800-469-7423) The Investor Relations website contains information about Myriad Genetics, Inc.'s business for stockholders, potential investors, and financial analysts. About Myriad RBM Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. If you are a payer or insurance provider, please contact us to receive more information. rrogers@myriad.com, Scott Gleason EVP, Corporate Communications sgleason@myriad.com, 800 4-MYRIAD (800 469-7423) (801) 584-3065 320 Wakara Way Myriad Genetics is a leading molecular diagnostics and precision medicine company dedicated to saving and improving lives. The Investor Relations website contains information about Myriad Genetics, Inc.'s business for stockholders, potential investors, and financial analysts. rrogers@myriad.com, Scott Gleason (801) 584-1143 cscomments@myriad.com, Decrease costs while improving patient well-being, Accurate test results drive optimal treatments. Minimum 15 minutes delayed. Myriad Customer Service The closing price above is not necessarily indicative of future price They are also the first Luminex Partner. About Myriad RBM Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM, Inc. is the world's leading multiplexed immunoassay development and testing laboratory. Ron Rogers NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been occurred for this security since the date shown above. Salt Lake City, UT 84108. The Split Adjustment Factor is a What You Need to Know About Hereditary Colon Cancer, Video – Pioneering Advances in Personalized Medicine, Myriad Genetics to Announce Quarterly Financial Results on November 9, 2020, Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results, Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results, Myriad Genetics Reports Fiscal Second-Quarter 2020 Financial Results, Myriad Genetics Reports Fiscal First-Quarter 2020 Financial Results, Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results, Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial Results, Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results, Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results, Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results, Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results, Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results, Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results, Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results, Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results, Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results, Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results, Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results, Myriad Genetics Reports Fiscal Third-Quarter 2016 Financial Results, Myriad Genetics Reports Fiscal Second-Quarter 2016 Financial Results, Myriad Genetics Reports Fiscal First-Quarter 2016 Financial Results, Myriad Genetics Reports Fiscal Fourth-Quarter and Full Year 2015 Financial Results, Myriad Genetics Reports Fiscal Third-Quarter 2015 Financial Results, Myriad Genetics Reports Fiscal Second-Quarter 2015 Financial Results, Myriad Genetics Reports Fiscal First Quarter 2015 Financial Results, Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2014 Financial Results, Myriad Genetics Reports Financial Results for Third Quarter of Fiscal Year 2014, Myriad Genetics Reports Financial Results for Second Quarter of Fiscal Year 2014, Myriad Genetics Reports Financial Results for First Quarter of Fiscal Year 2014, Myriad Genetics Reports Full-Year and Fiscal Fourth-Quarter 2013 Financial Results, Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results, Myriad Genetics Reports Second Quarter Fiscal Year 2013 Results, Myriad Genetics Reports First Quarter Fiscal Year 2013 Results, Notice and Statement Concerning Nondiscrimination and Accessibility.